Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — ESG Presentation (2021)
15 slides from Coloplast A/s Class B's sustainability presentation, 2021
Slide 1: Sustainable growth leadership
Strive 25: Sustainable growth Stina leadership Sustainability at Coloplast Making life easier
Slide 2: Our Strive25 strategy will drive continued long-term value creation
Our Strive25 strategy will drive continued long-term value creation through revenue and earnings growth Chronic Care Interventional Wound & Urology Skin Care 7-9% more than30% organic growth p.a. EBIT margin1 Talent, Innovation Leadership & Culture Unparalleled Sustainability efficiency 1) Constant
Slide 3: Our plastic position
Our plastic position As a manufacturer of medical products made of plastic, Coloplast has a responsibility. We embrace that responsibility and have clear priorities: • Product safety and clinical performance cannot be compromised • Single use products are the easiest and safest option for our users
Slide 4: Supporting sustainable development with a strong emphasis on improving our environmental performance
Supporting sustainable development with a strong emphasis on improving our environmental performance Our mission Making life easier for people with intimate healthcare needs Stina Our 2025 priority Our 2025 priority Improving Reducing products and emissions packaging 90% of packaging is recyclable N
Slide 5: Our 2025 priority: Improving products and packaging
Our 2025 priority: Improving products and packaging Improving products and packaging by addressing material use Improving products and packaging FY 2020/21 progress on key sustainability ambitions1) Why is this a key priority: 2025 FY FY As a manufacturer of medical products primarily made of Ambiti
Slide 6: Our 2025 priority: Reducing emissions
Our 2025 priority: Reducing emissions We are committed to reducing emissions while being a growth company Reducing emissions FY 2020/21 progress on key sustainability ambitions1) 2025 FY FY Why is this a key priority: Ambition 20/21 19/20 As a growing company, we are challenged by a potential Scope
Slide 7: Coloplast is committed to ambitious science-based climate action
Coloplast is committed to ambitious science-based climate action for a 1.5°C future
Slide 8: Climate risk is financial risk and thus we support the TCFD recommendations
Climate risk is financial risk and thus we support the TCFD recommendations We support the TCFD recommendations and have decided to take a step-by-step approach to report according to the TCFD framework and will step-wise increase our disclosure in the coming years. We will report results from our c
Slide 9: Our ongoing commitment: Responsible operations
Our ongoing commitment: Responsible operations Strong commitment to responsible operations which is our core values Responsible operations FY 2020/21 progress on key sustainability ambitions1) 2025 FY FY Why is this a key priority: Ambition 20/21 19/20 100% 99% 98% Our people and culture are at the
Slide 10: Our ongoing commitment: Raising standards of care
Our ongoing commitment: Raising standards of care We have initiated an ambitious Clinical Performance Program to tackle the biggest issues users face Users are challenged by skin irritation and urinary tract We have made progress on key technologies and infections run clinical trials Intermittent 91
Slide 11: Our ongoing commitment: Raising standards of care
Our ongoing commitment: Raising standards of care Our global Coloplast Care and DtC presence enable us to support users across countries and business areas Over 2.0M consumers in our database Over 3.6M conversations with users across the globe Over 30 countries with a consumer setup Coloplast Care &
Slide 12: Our ongoing commitment: Raising standards of care
Our ongoing commitment: Raising standards of care Our Professional platform builds a strong connection with HCPs, providing valuable insights to Coloplast Care Coloplast Professional is an education and …and input from local clinicians While our training yields best collaboration platform… advance C
Slide 13: Our ongoing commitment: Raising standards of care
Our ongoing commitment: Raising standards of care Partnerships and our Access to Healthcare program have enabled increased standards of care across the globe IC reimbursement has been introduced in Japan, South Korea Access to Healthcare program and Australia over the past 5 years Our partnership pr
Slide 14: Our Sustainability Governance
Our Sustainability Governance We have strengthened our governance of Sustainability Remuneration and Nomination Committee Board of Directors Consists of three members appointed among the Consists of six shareholder-elected and three employee- Board of Directors. elected members. Audit Committee Cons
Slide 15: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /